CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (5,613,646)	$ (5,921,077)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	141,604	232,724
Stock-based compensation	432,758	757,338
Amortization of debt issuance costs		9,120
Provision for bad debts	0	(8,633)
Change in operating assets and liabilities:
Accounts receivable	290,828	1,178,367
Inventories	53,688	(93,306)
Prepaid expenses and other current assets and deposits	(87,114)	37,393
Accounts payable and accrued liabilities	(424,631)	157,493
Deferred revenue	42,533	(151,444)
Net cash used in operating activities	(5,151,404)	(3,802,025)
Cash flows from investing activities:
Purchase of property and equipment	(8,227)	(63,986)
Purchase of intangible asset	(36,525)	0
Net cash used in investing activities	(44,752)	(63,986)
Cash flows from financing activities:
Proceeds from Promissory notes (related parties $550,000)	0	550,000
Net proceeds from exercise of warrants	2,768,133	718,064
Net proceeds from sale of common stock and warrants	10,639,728	2,479,524
Repayment of convertible notes	(107,802)	0
Net cash provided by financing activities	13,300,059	3,747,588
Net increase (decrease) in cash and cash equivalents	8,103,903	(118,423)
Cash and cash equivalents at beginning of period	558,988	1,659,564
Cash and cash equivalents at end of period	8,662,891	1,541,141
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest	0	0
Cash paid during period for income taxes	0	0
Non-cash investing and financing activities:
Impact of adoption of new accounting pronouncements included in accumulated deficit	0	493,223
Interest paid in kind (related party of $35,550 for the six month period ended March 31, 2019)	35,625	48,816
Offering costs incurred, and included in accounts payable	0	15,933
Property and equipment acquired, and included in accounts payable	109,423	0
Deemed dividend-warrant repricing	2,842	0
Deferred offering costs reclassified to additional paid in capital	109,698	0
Intangible asset costs incurred, and included in accounts payable	$ 14,375	$ 0